4-hydroxyphenyllactic acid has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajmera, VH; Bassirian, S; Bettencourt, R; Brenner, DA; Caussy, C; Chen, CH; Hooker, J; Hsu, C; Liu, A; Lo, MT; Loomba, R; Richards, L; Schnabl, B; Schork, N; Sirlin, CB; Sy, E | 1 |
| Bucsis, L; Flasshoff, HJ; Müting, D; Wuzel, H | 1 |
2 other study(ies) available for 4-hydroxyphenyllactic acid and Cirrhosis, Liver
| Article | Year |
|---|---|
Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD.
Topics: Adult; Aged; Cross-Sectional Studies; Female; Gastrointestinal Microbiome; Humans; Liver Cirrhosis; Male; Metformin; Middle Aged; Non-alcoholic Fatty Liver Disease; Phenylpropionates; Proof of Concept Study | 2018 |
Urinary p-hydroxyphenyllactic acid as indicator of hepatic encephalopathy in patients with hepatic cirrhosis.
Topics: Adult; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Phenylpropionates | 1985 |